Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded […]readmore
Tags : Lotus
Shots: Lotus to get an exclusive commercialization right of biosimilar Darbepoetin alfa in Taiwan and Southeast Asian markets The collaboration allows the Lotus to re-emphasize its focus on nephrology as […]readmore